INMD
InMode Ltd. NASDAQ Listed Aug 8, 2019$13.92
Mkt Cap $882.0M
52w Low $12.72
29.9% of range
52w High $16.74
50d MA $13.83
200d MA $14.47
P/E (TTM)
9.9x
EV/EBITDA
5.9x
P/B
1.4x
Debt/Equity
0.0x
ROE
29.0%
P/FCF
11.3x
RSI (14)
—
ATR (14)
—
Beta
2.12
50d MA
$13.83
200d MA
$14.47
Avg Volume
1.1M
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Tavor Building · Yokne'am, L3 2069206 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 0.30 | 0.25 | -16.1% | 13.59 | +0.0% | +2.4% | — | — | — | — | — |
| Feb 10, 2026 | AMC | 0.42 | 0.46 | +10.5% | 14.62 | +0.9% | -2.6% | +0.4% | +0.0% | +1.3% | -0.1% | — |
| Nov 5, 2025 | AMC | 0.35 | 0.38 | +8.3% | 14.53 | -1.6% | -0.6% | +0.1% | +1.0% | -0.6% | +0.7% | — |
| Jul 30, 2025 | AMC | 0.43 | 0.47 | +9.3% | 13.90 | -0.6% | -1.7% | +0.6% | +2.4% | +0.4% | -1.1% | — |
| Apr 28, 2025 | AMC | 0.33 | 0.31 | -6.1% | 14.26 | -0.4% | +1.1% | -2.2% | +4.3% | -0.9% | -2.2% | — |
| Feb 4, 2025 | AMC | 0.50 | 0.42 | -16.0% | 17.50 | +0.7% | +2.6% | +1.6% | -1.2% | +2.8% | +0.2% | — |
| Oct 30, 2024 | AMC | 0.63 | 0.70 | +11.1% | 17.87 | +0.1% | -4.4% | +1.1% | +0.7% | +3.0% | +7.7% | — |
| Aug 1, 2024 | AMC | 0.38 | 0.34 | -10.5% | 16.57 | -3.1% | +3.6% | -3.9% | +2.6% | -2.2% | +1.4% | — |
| May 2, 2024 | AMC | 0.41 | 0.32 | -22.0% | 17.36 | +2.1% | +1.6% | +5.7% | -0.8% | -1.1% | +0.3% | — |
| Feb 13, 2024 | AMC | 0.67 | 0.71 | +6.0% | 23.67 | +1.4% | -3.3% | +3.8% | -4.1% | -8.0% | -0.6% | — |
| Nov 2, 2023 | AMC | 0.64 | 0.61 | -4.7% | 21.76 | +0.3% | -1.3% | -4.7% | -3.9% | +1.6% | -1.5% | — |
| Jul 27, 2023 | AMC | 0.64 | 0.72 | +12.5% | 44.06 | +1.5% | -2.7% | +0.1% | +2.2% | -1.0% | -0.9% | — |
| May 2, 2023 | TNS | 0.47 | 0.52 | +10.6% | 33.83 | +1.2% | -0.4% | -4.3% | +4.4% | +3.8% | -0.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 | Canaccord Genuity | Maintains | Hold → Hold | — | $14.48 | $14.31 | -1.2% | -1.2% | +1.7% | -1.4% | +0.5% | -0.4% |
| Nov 6 | UBS | Maintains | Neutral → Neutral | — | $14.53 | $14.30 | -1.6% | -0.6% | +0.1% | +1.0% | -0.6% | +0.7% |
| Oct 10 | Needham | Maintains | Hold → Hold | — | $15.89 | $16.00 | +0.7% | -3.9% | +0.2% | +0.9% | -1.1% | -0.3% |
| Oct 10 | Canaccord Genuity | Maintains | Hold → Hold | — | $15.89 | $16.00 | +0.7% | -3.9% | +0.2% | +0.9% | -1.1% | -0.3% |
| Jul 30 | Needham | Maintains | Hold → Hold | — | $14.31 | $14.02 | -2.0% | -2.9% | -1.7% | +0.6% | +2.4% | +0.4% |
| Jul 30 | Barclays | Maintains | Overweight → Overweight | — | $14.31 | $14.02 | -2.0% | -2.9% | -1.7% | +0.6% | +2.4% | +0.4% |
| Jul 11 | Canaccord Genuity | Maintains | Hold → Hold | — | $15.18 | $15.07 | -0.7% | -3.1% | +0.2% | -3.3% | +0.1% | -1.1% |
| Apr 30 | Barclays | Maintains | Overweight → Overweight | — | $14.42 | $14.23 | -1.3% | -2.2% | +4.3% | -0.9% | -2.2% | +0.4% |
| Apr 29 | Canaccord Genuity | Maintains | Hold → Hold | — | $14.26 | $14.21 | -0.4% | +1.1% | -2.2% | +4.3% | -0.9% | -2.2% |
| Apr 29 | BTIG | Downgrade | Buy → Neutral | — | $14.26 | $14.21 | -0.4% | +1.1% | -2.2% | +4.3% | -0.9% | -2.2% |
| Apr 29 | UBS | Maintains | Neutral → Neutral | — | $14.26 | $14.21 | -0.4% | +1.1% | -2.2% | +4.3% | -0.9% | -2.2% |
| Apr 28 | Needham | Maintains | Hold → Hold | — | $16.22 | $14.33 | -11.7% | -12.1% | +1.1% | -2.2% | +4.3% | -0.9% |
| Apr 14 | Jefferies | Maintains | Hold → Hold | — | $14.88 | $15.10 | +1.5% | +1.3% | +2.2% | -3.2% | +0.1% | -0.8% |
| Apr 14 | Needham | Maintains | Hold → Hold | — | $14.88 | $15.10 | +1.5% | +1.3% | +2.2% | -3.2% | +0.1% | -0.8% |
| Apr 9 | Needham | Maintains | Hold → Hold | — | $14.48 | $14.50 | +0.1% | +6.8% | -8.8% | +5.5% | +1.3% | +2.2% |
| Feb 5 | Barclays | Maintains | Overweight → Overweight | — | $17.50 | $17.62 | +0.7% | +2.6% | +1.6% | -1.2% | +2.8% | +0.2% |
| Feb 4 | Needham | Maintains | Hold → Hold | — | $16.67 | $17.20 | +3.2% | +5.0% | +2.6% | +1.6% | -1.2% | +2.8% |
| Jan 9 | Barclays | Maintains | Overweight → Overweight | — | — | — | — | — | — | — | — | — |
| Oct 14 | Barclays | Maintains | Overweight → Overweight | — | $16.50 | $16.22 | -1.7% | +0.9% | +0.0% | +1.4% | +2.0% | +3.3% |
| Jul 23 | Jefferies | Downgrade | Buy → Hold | — | $17.75 | $17.01 | -4.2% | +0.5% | -0.8% | -0.6% | +1.6% | +0.7% |
| Jul 15 | Barclays | Maintains | Overweight → Overweight | — | $17.87 | $17.96 | +0.5% | -0.2% | +6.9% | -1.8% | -4.2% | -1.4% |
| Jul 12 | Canaccord Genuity | Maintains | Hold → Hold | — | $16.82 | $16.98 | +1.0% | +6.2% | -0.2% | +6.9% | -1.8% | -4.2% |
| Apr 12 | Barclays | Maintains | Overweight → Overweight | — | $18.47 | $18.20 | -1.5% | -3.0% | -1.3% | -0.4% | -1.0% | -0.6% |
| Feb 15 | Barclays | Maintains | Overweight → Overweight | — | $22.90 | $23.26 | +1.6% | +3.8% | -4.1% | -8.0% | -0.6% | -0.7% |
| Feb 14 | UBS | Maintains | Neutral → Neutral | — | $23.67 | $24.00 | +1.4% | -3.3% | +3.8% | -4.1% | -8.0% | -0.6% |
| Jan 18 | Barclays | Maintains | Overweight → Overweight | — | $21.88 | $22.04 | +0.7% | +4.7% | -1.4% | +2.1% | -0.3% | -1.2% |
| Jan 4 | Barclays | Maintains | Overweight → Overweight | — | $21.00 | $20.96 | -0.2% | +0.0% | -0.2% | +2.0% | +3.3% | -0.6% |
| Dec 7 | Canaccord Genuity | Maintains | Hold → Hold | — | $21.26 | $21.31 | +0.2% | -2.4% | +4.8% | -0.9% | -3.0% | +5.4% |
| Nov 3 | UBS | Downgrade | Buy → Neutral | — | $21.76 | $21.83 | +0.3% | -1.3% | -4.7% | -3.9% | +1.6% | -1.5% |
| Oct 13 | Canaccord Genuity | Downgrade | Buy → Hold | — | $22.40 | $22.31 | -0.4% | -7.4% | +2.7% | -0.4% | -2.3% | -4.2% |
| Aug 1 | Barclays | Maintains | Overweight → Overweight | — | $42.91 | $42.81 | -0.2% | +2.2% | -1.0% | -0.9% | -0.7% | +0.6% |
| Jul 28 | Baird | Maintains | Outperform → Outperform | — | $44.06 | $44.73 | +1.5% | -2.7% | +0.1% | +2.2% | -1.0% | -0.9% |
| Jul 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $44.06 | $44.73 | +1.5% | -2.7% | +0.1% | +2.2% | -1.0% | -0.9% |
| May 4 | Barclays | Maintains | Overweight → Overweight | — | $33.71 | $33.70 | -0.0% | -4.3% | +4.4% | +3.8% | -0.7% | -0.7% |
| Feb 17 | Needham | Downgrade | Buy → Hold | — | $39.69 | $37.56 | -5.4% | -6.7% | -3.3% | +0.7% | -0.3% | -3.2% |
| Feb 15 | Barclays | Maintains | Overweight → Overweight | — | $37.57 | $37.20 | -1.0% | +10.3% | -4.2% | -6.7% | -3.3% | +0.7% |
| Jul 29 | Needham | Maintains | Buy → Buy | — | $33.35 | $33.04 | -0.9% | -0.3% | +3.3% | -1.1% | +7.0% | +2.6% |
| Jun 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $23.26 | $22.86 | -1.7% | -3.7% | +0.4% | +6.1% | -3.7% | +3.5% |
| May 3 | Needham | Maintains | Buy → Buy | — | $25.61 | $25.79 | +0.7% | +1.7% | +5.1% | -9.0% | -2.3% | -10.1% |
| Feb 11 | Needham | Maintains | Buy → Buy | — | $51.34 | $50.73 | -1.2% | -8.4% | -3.0% | +3.9% | -1.9% | -8.5% |
| Oct 27 | Canaccord Genuity | Maintains | Buy → Buy | — | $87.51 | $87.00 | -0.6% | -5.3% | +7.4% | +6.4% | +3.3% | +0.0% |
| Oct 13 | Barclays | Maintains | Overweight → Overweight | — | $75.44 | $78.33 | +3.8% | +13.8% | -0.8% | -2.1% | +2.0% | -0.3% |
| Oct 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $75.44 | $78.33 | +3.8% | +13.8% | -0.8% | -2.1% | +2.0% | -0.3% |
| Oct 12 | Needham | Maintains | Buy → Buy | — | $69.45 | $77.00 | +10.9% | +8.6% | +13.8% | -0.8% | -2.1% | +2.0% |
| Sep 27 | Needham | Maintains | Buy → Buy | — | $88.24 | $89.86 | +1.8% | -3.2% | -12.8% | +7.0% | -0.1% | -1.1% |
| Jul 29 | Needham | Maintains | Buy → Buy | — | $55.37 | $55.35 | -0.0% | +4.8% | -2.0% | +1.0% | +0.3% | +0.6% |
| Jul 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $55.37 | $55.35 | -0.0% | +4.8% | -2.0% | +1.0% | +0.3% | +0.6% |
| Jul 13 | Barclays | Maintains | Overweight → Overweight | — | $54.10 | $54.29 | +0.4% | +0.5% | -3.2% | -2.6% | +3.2% | +0.3% |
| Jul 12 | Needham | Maintains | Buy → Buy | — | $48.07 | $50.39 | +4.8% | +12.5% | +0.5% | -3.2% | -2.6% | +3.2% |
| May 6 | Baird | Maintains | Outperform → Outperform | — | $40.60 | $40.28 | -0.8% | -7.2% | +2.3% | -5.9% | +1.8% | -4.4% |
No insider trades available.
No recent filings available.
Data updated apr 25, 2026 3:41pm
· Source: massive.com